Publications

Malaria and complex emergencies.

ROWLAND, M; WEBSTER, J; Meek, S;

2002

Health Action, (2002).26 May-Au

Natural Products as potential antiparasitic drugs.

Kayser, O; Kiderlen, A; CROFT, SL;

2002

Studies in Natural Product Chemistry 26 , Elsevier (2002).

Northfield, J; WHITTY, CJ M; MacPhee, IA M;

2002

Nephrology, dialysis, transplantation, (2002).17 1 10.1093/ndt/17.1.137.

Private sector availability of drugs for the treatment of malaria and fever in rural Tanzania.

MILLS, A; Goodman, C; Kachur, P; Khatibu, R; Abdulla, S; Bloland, P;

2002

Multilateral Initiative on Malaria African Malaria Conference (2002).

The nature of retail competition in the market for fever and malaria drugs in rural Tanzania.

MILLS, A; Goodman, C; Abdulla, S; Bloland, P;

2002

Multilateral Initiative on Malaria African Malaria Conference (2002).

Country case study: Zambia.

Nakamba, PM; Hongoro, C; McPake, B; HANSON, K; Chirwa, BU; Sund, BB;

2002

Health Sector Reforms: What about hospitals? , Nordic School of Public Health (G?tenborg, Sweden) (2002).

Country case study: Uganda.

Ssengooba, F; McPake, B; Hongoro, C; HANSON, K; Okuonzi, S;

2002

Health Sector Reforms: What about hospitals? , Nordic School of Public Health (G?tenborg, Sweden) (2002).

Verardi, A; Donnelly, MJ; ROWLAND, M; Townson, H;

2002

Molecular ecology notes, (2002).2 4 10.1046/j.1471-8278.2002.00288.x.

Costing the implementation of the change in first-line drug for malaria treatment in Tanzania.

MILLS, A; Mulligan, J; Mandike, R; Palmer, N; Holly, WA; S, A; Bloland, P;

2002

Multilateral Initiative on Malaria African Malaria Conference (2002).

Modelling the cost effectiveness of combination therapy and drug resistance.

MILLS, A; YEUNG, S; Pongtavornpinyo, W; Hastings, I; White, N;

2002

Multilateral Initiative on Malaria African Malaria Conference (2002).